Coordinated regulation of ribosomes and proteasomes by PRMT1 in the maintenance of neural stemness of cancer cells and neural stem cells
L. Chen, M. Zhang, L. Fang, X. Yang, L. Xu, L. Shi, N. Cao, Y. Cao
Abstract
Our studies suggest that neural stemness contributes to cell tumorigenicity. The basic cell physiological machineries and developmental programs, such as cell cycle, ribosomes, proteasomes, epigenetic factors, etc., which are upregulated in and promote cancers, are enriched in embryonic neural cells. How these machineries are coordinated is unknown. Here, we show that loss of neural stemness in cancer cells or neural stem cells leads to simultaneous downregulation of components of ribosomes and proteasomes, which are responsible for protein synthesis and degradation, respectively, and downregulation of major epigenetic factors. Inhibition of PRMT1 causes neuron-like differentiation, downregulation of a similar set of proteins, and alteration of subcellular localization of ribosome and proteasome components. PRMT1 interacts with these components, catalyzes arginine methylation of them and protects them from degradation, thereby maintaining a high level of expression of epigenetic factors that maintain neural stemness. PRMT1 inhibition results in repression of cell tumorigenicity. Therefore, PRMT1 coordinates ribosomes and proteasomes to match the needs for high protein production and protein homeostasis in cells with fast cell cycle and proliferation.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neural stemness unifies cell tumorigenicity and pluripotent differentiation potential
- Onset of differentiation is posttranscriptionally controlled in adult neural stem cells
Avni Baser, Maxim A. Skabkin, … Ana Martín-Villalba·NaturePeer-reviewed·Jan 30, 2019
- Increased activity of PRMT5-MEP50 complex improves survival of chromosomally unstable cancer cells by increasing tolerance to protein aggregation and proteotoxicity
Maria F. Suárez Peredo Rodríguez, Laura J. Jilderda, … Floris Foijer·bioRxiv·Sep 12, 2025
- PRMT5 activity sustains histone production to maintain genome integrity
Jacob S. Roth, Joseph D. DeAngelo, … David Shechter·bioRxiv·Jul 3, 2025
- PRMT5 orchestrates EGFR and AKT networks to activate NFκB and promote EMT
Lei Huang, Manasa Ravi, … Qiong Wu·bioRxiv·Jan 3, 2024
- NRF1 and NRF3 complementarily maintain a basal proteasome activity in cancer cells through CPEB3-mediated translational repression
Tsuyoshi Waku, Hiroyuki Katayama, … Akira Kobayashi·Molecular and Cellular BiologyPeer-reviewed·May 4, 2020